NORDH — Nordhealth AS Income Statement
0.000.00%
Last trade - 00:00- NOK2.85bn
- NOK2.61bn
- €45.68m
- 61
- 11
- 87
- 53
Annual income statement for Nordhealth AS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | — | NAS | NAS | NAS | NAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.7 | 20.3 | 31.1 | 36.8 | 45.7 |
| Cost of Revenue | |||||
| Gross Profit | 10.9 | 16.7 | 26.3 | 31.7 | 39 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.7 | 24.8 | 45.7 | 48.2 | 53.4 |
| Operating Profit | 1.98 | -4.46 | -14.7 | -11.4 | -7.73 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2 | -4.65 | -14.1 | -10.8 | -6.64 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.93 | -4.73 | -14.3 | -11.1 | -7.67 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.93 | -4.73 | -14.3 | -11.1 | -7.67 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.93 | -4.73 | -14.3 | -11.1 | -7.67 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.03 | -0.022 | -0.093 | -0.055 | -0.015 |
| Dividends per Share |